76 related articles for article (PubMed ID: 12404122)
1. Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation.
Cesi V; Tanno B; Vitali R; Mancini C; Giuffrida ML; Calabretta B; Raschellà G
Cell Death Differ; 2002 Nov; 9(11):1232-9. PubMed ID: 12404122
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
3. Regulation of B-Myb activity by cyclin D1.
Horstmann S; Ferrari S; Klempnauer KH
Oncogene; 2000 Jan; 19(2):298-306. PubMed ID: 10645009
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
5. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
Joaquin M; Bessa M; Saville MK; Watson RJ
Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
[TBL] [Abstract][Full Text] [Related]
6. B-myb transcriptional regulation and mRNA stability during differentiation of neuroblastoma cells.
Raschellà G; Negroni A; Pucci S; Amendola R; Valeri S; Calabretta B
Exp Cell Res; 1996 Feb; 222(2):395-9. PubMed ID: 8598228
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells.
Raschellà G; Tanno B; Bonetto F; Negroni A; Amendola R; Paggi MG
Med Pediatr Oncol; 2001 Jan; 36(1):104-7. PubMed ID: 11464857
[TBL] [Abstract][Full Text] [Related]
8. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Petrovas C; Jeay S; Lewis RE; Sonenshein GE
Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
[TBL] [Abstract][Full Text] [Related]
9. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
Lane S; Farlie P; Watson R
Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
[TBL] [Abstract][Full Text] [Related]
10. B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: implications for cell survival.
Schwab R; Caccamo A; Bettuzzi S; Anderson J; Sala A
Blood Cells Mol Dis; 2007; 39(3):263-71. PubMed ID: 17588787
[TBL] [Abstract][Full Text] [Related]
11. B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter.
Kamano H; Klempnauer KH
Oncogene; 1997 Mar; 14(10):1223-9. PubMed ID: 9121772
[TBL] [Abstract][Full Text] [Related]
12. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
Horstmann S; Ferrari S; Klempnauer KH
Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
[TBL] [Abstract][Full Text] [Related]
13. The cooperation of B-Myb with the coactivator p300 is orchestrated by cyclins A and D1.
Schubert S; Horstmann S; Bartusel T; Klempnauer KH
Oncogene; 2004 Feb; 23(7):1392-404. PubMed ID: 14973551
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic sequestration of cyclin D1 associated with cell cycle withdrawal of neuroblastoma cells.
Sumrejkanchanakij P; Eto K; Ikeda MA
Biochem Biophys Res Commun; 2006 Feb; 340(1):302-8. PubMed ID: 16364255
[TBL] [Abstract][Full Text] [Related]
15. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
16. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of benzo(a)pyrene-induced cell cycle progression by all-trans retinoic acid partly through cyclin D1/E2F-1 pathway in human embryo lung fibroblasts.
Jia X; Liu B; Shi X; Gao A; You B; Ye M; Shen F; Du H
Cell Biol Int; 2006 Feb; 30(2):183-9. PubMed ID: 16406622
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the cell cycle by B-Myb.
Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ
Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164
[TBL] [Abstract][Full Text] [Related]
20. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
